Search for: "Doe v. Holder"
Results 341 - 360
of 6,687
Sort by Relevance
|
Sort by Date
7 Apr 2023, 10:51 am
Avoids problems of regulatory arbitrage. 230 v. [read post]
6 Apr 2023, 3:30 am
After Cohen, in Holder v. [read post]
6 Apr 2023, 12:31 am
Does that term make anyone wince? [read post]
5 Apr 2023, 1:46 pm
In Intel v. [read post]
5 Apr 2023, 1:28 am
Daimler and Nokia v. [read post]
4 Apr 2023, 10:17 pm
v. [read post]
4 Apr 2023, 3:42 am
See, e.g., In re S’holders Data Corp., 495 F.2d 1360, 181 USPQ 722, 723 (CCPA 1974) ("Although the Act does not define 'goods,' the definition of a 'trademark' in section 45 declares that it is used 'to identify goods' and section 2 refers to 'goods in commerce.'"). [read post]
4 Apr 2023, 2:30 am
In 2018, the Supreme Court decided in SAS Institute, Inc. v. [read post]
3 Apr 2023, 6:56 pm
LLC v. [read post]
2 Apr 2023, 11:52 pm
Only in this context does the draft regulation explicitly rule out further "review". [read post]
2 Apr 2023, 1:02 am
The order in which I do so does not indicate a prioritization. [read post]
31 Mar 2023, 7:13 am
Therefore, it is key to give leverage reasonably early to SEP holders. [read post]
30 Mar 2023, 12:27 pm
In Polselli v. [read post]
28 Mar 2023, 9:35 am
In 1952, the court held in Steele v. [read post]
27 Mar 2023, 9:01 pm
In a direct listing, however, the company does not typically issue new shares. [read post]
27 Mar 2023, 1:38 pm
See Rogers v. [read post]
27 Mar 2023, 1:38 pm
See Rogers v. [read post]
How Has Blockchain Technology Fared in China? –from a case study of LRB to the most recent NFT cases
27 Mar 2023, 9:50 am
In the spirit of community building, not only does a collector have access to her own collection, but she can also enjoy others’ collections by visiting their R-Space. [read post]
23 Mar 2023, 10:00 am
In an unpublished opinion in the case, Evox Productions, LLC v. [read post]
23 Mar 2023, 5:32 am
There is no provision allowing requests for excluding an indication from generics and branded generics labels when it does not result from a previous change in the reference-listed drug’s label. [read post]
